BioSpace News Archive

Thermo Fisher Scientific, the world leader in serving science, today announced it has updated its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel to detect the Delta and Lambda strains.

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced financial results for the three and six months ended June 30, 2021 and highlighted recent corporate updates.

Harmony Biosciences Holdings, Inc. (“Harmony”) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological diseases, today announced the acquisition of HBS-102 (formerly CSTI-100),

Genentech, a member of the Roche Group, announced that the pivotal Phase III POLARIX trial investigating Polivy® in combination with Rituxan® plus cyclophosphamide, doxorubicin and prednisone versus Rituxan plus cyclophosphamide, doxorubicin, vincristine and prednisone met its primary endpoint by demonstrating significantly improved and clinically meaningful progression-free survival in people with previously untreated diffuse large B-cell lymphoma.

Orthokeratology is the use of contact lenses that are gas-permeable in order to reshape the cornea of the eye.

NGS is the term which is used to describe a number of different modern sequencing technologies and is also known as high throughput sequencing.

Transparency Market Research has published a new report titled ‘Healthcare Information Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global health care information systems market was valued at US$ 227,021.4 Mn in 2017 and is projected to expand at a CAGR of 9.6% from 2018 to 2026.

Biopreservation is a process for conserving the tissues, organs and cells along with maintaining their integrity and functionality at different temperatures for a prolonged period of time.

Mission Therapeutics, a drug discovery and development company focused on targeting the ubiquitin pathway, and AbbVie announced progression of selected deubiquitylating enzyme targets into the next phase of research in their neurodegenerative disease collaboration.

Amneal Pharmaceuticals, Inc. announced its results for the second quarter ended June 30, 2021.